ABC transporters and the blood-brain barrier.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Current pharmaceutical design

• Publication date

  2004-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/1381612043384844PMID 15134482
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of P-Glycoprotein by Newer Antidepressants

  2003cited by this paper
• Is obesity a disease of the blood-brain barrier? Physiological, pathological, and evolutionary considerations.

  2003cited by this paper
• Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease.

  2003cited by this paper
• Interactions of cytokines with the blood-brain barrier: implications for feeding.

  2003cited by this paper
• Apparent Lack of Mrp1-Mediated Efflux at the Luminal Side of Mouse Blood-Brain Barrier Endothelial Cells

  2003cited by this paper
• Vascular and parenchymal mechanisms in multiple drug resistance: a lesson from human epilepsy.

  2003cited by this paper
• Modulation of P‐glycoprotein but not MRP1‐ or BCRP‐mediated drug resistance by LY335979

  2003cited by this paper
• Drug efflux transporters in the CNS.

  2003cited by this paper
• New malaria chemotherapy developed by utilization of a unique parasite transport system.

  2003cited by this paper
• Increased penetration of paclitaxel into the brain by inhibition of P-Glycoprotein.

  2003cited by this paper
• Effect of efflux inhibition on brain uptake of itraconazole in mice infected with Cryptococcus neoformans.

  2003cited by this paper
• Multidrug Resistance Protein MRP2 Contributes to Blood-Brain Barrier Function and Restricts Antiepileptic Drug Activity

  2003cited by this paper
• Mechanisms of antiepileptic drug resistance

  2003cited by this paper
• Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1.

  2003cited by this paper
• P-glycoprotein limits the brain penetration of nonsedating but not sedating H1-antagonists.

  2003cited by this paper
• Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood-brain barrier.

  2003cited by this paper
• Drug transport to the brain: key roles for the efflux pump P-glycoprotein in the blood-brain barrier.

  2002cited by this paper
• GF120918, a P-Glycoprotein Modulator, Increases the Concentration of Unbound Amprenavir in the Central Nervous System in Rats

  2002cited by this paper
• A new multidrug resistance protein at the blood-brain barrier.

  2002cited by this paper
• Role of transporters in the tissue-selective distribution and elimination of drugs: transporters in the liver, small intestine, brain and kidney.

  2002cited by this paper
• Expression of P-Glycoprotein in Human Cerebral Cortex Microvessels

  2002cited by this paper
• Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans.

  2002cited by this paper
• By-passing of P-glycoprotein Using Immunoliposomes

  2002cited by this paper
• C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance.

  2002cited by this paper
• Drug Transport into the Mammalian Brain: The Nasal Pathway and its Specific Metabolic Barrier

  2002cited by this paper
• Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo.

  2002cited by this paper
• Application of three-dimensional quantitative structure-activity relationships of P-glycoprotein inhibitors and substrates.

  2002cited by this paper
• Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein.

  2002cited by this paper
• Mechanism of ABC transporters: A molecular dynamics simulation of a well characterized nucleotide-binding subunit

  2002cited by this paper
• P-Glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood-brain barrier: evidence from microdialysis experiments in rats.

  2002cited by this paper
• Regulation of Expression of the Multidrug Resistance-Associated Protein 2 (MRP2) and Its Role in Drug Disposition

  2002cited by this paper
• Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain Barrier

  2002cited by this paper
• Single nucleotide polymorphisms in multidrug resistance associated protein 2 (MRP2/ABCC2): its impact on drug disposition.

  2002cited by this paper
• [Grapefruit juice and drugs: a hazardous combination?].

  2002cited by this paper
• Increased CNS uptake and enhanced antinociception of morphine‐6‐glucuronide in rats after inhibition of P‐glycoprotein

  2002cited by this paper
• Localisation of breast cancer resistance protein in microvessel endothelium of human brain

  2002cited by this paper
• Mammalian ABC transporters in health and disease.

  2002cited by this paper
• Choroid Plexus Transporters for Drugs and Other Xenobiotics

  2002cited by this paper
• The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans.

  2002cited by this paper
• Passive Permeability and P-Glycoprotein-Mediated Efflux Differentiate Central Nervous System (CNS) and Non-CNS Marketed Drugs

  2002cited by this paper
• Drug and gene targeting to the brain with molecular trojan horses

  2002cited by this paper
• Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations.

  2001cited by this paper
• Circumvention of breast cancer resistance protein (BCRP)-mediated resistance to camptothecins in vitro using non-substrate drugs or the BCRP inhibitor GF120918.

  2001cited by this paper
• Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells.

  2001cited by this paper
• Doxorubicin-peptide conjugates overcome multidrug resistance

  2001cited by this paper
• Screening of Multidrug-Resistance Sensitive Drugs by In Situ Brain Perfusion in P-Glycoprotein-Deficient Mice

  2001cited by this paper
• Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene.

  2001cited by this paper
• Affinity for the P-Glycoprotein Efflux Pump at the Blood-Brain Barrier May Explain the Lack of CNS Side-Effects of Modern Antihistamines

  2001cited by this paper
• Major Photoaffinity Drug Binding Sites in Multidrug Resistance Protein 1 (MRP1) Are within Transmembrane Domains 10–11 and 16–17*

  2001cited by this paper
• Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues.

  2001cited by this paper
• The human ATP-binding cassette (ABC) transporter superfamily.

  2001cited by this paper
• Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: saturation kinetics and specificity.

  2001cited by this paper
• Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells.

  2001cited by this paper
• Inhibition of BCRP-mediated drug efflux by fumitremorgin-type indolyl diketopiperazines.

  2001cited by this paper
• Frequency of single nucleotide polymorphisms in the P‐glycoprotein drug transporter MDR1 gene in white subjects

  2001cited by this paper
• Nanoparticulate systems for brain delivery of drugs.

  2001cited by this paper
• Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene.

  2001cited by this paper
• beta-Amyloid efflux mediated by p-glycoprotein.

  2001cited by this paper
• Theoretical calculation and prediction of P-glycoprotein-interacting drugs using MolSurf parametrization and PLS statistics.

  2000cited by this paper
• Communication between multiple drug binding sites on P-glycoprotein.

  2000cited by this paper
• Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein.

  2000cited by this paper
• Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes.

  2000cited by this paper
• The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2).

  2000cited by this paper
• New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy.

  2000cited by this paper
• Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan.

  2000cited by this paper
• Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport

  2000cited by this paper
• A family of drug transporters: the multidrug resistance-associated proteins.

  2000cited by this paper
• Xenobiotic transport across isolated brain microvessels studied by confocal microscopy.

  2000cited by this paper
• Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier.

  2000cited by this paper
• Two transport binding sites of P-glycoprotein are unequal yet contingent: initial rate kinetic analysis by ATP hydrolysis demonstrates intersite dependence.

  2000cited by this paper
• Substrate recognition by P-glycoprotein and the multidrug resistance-associated protein MRP1: a comparison.

  2000cited by this paper
• Structure-activity relationship of P-glycoprotein substrates and modifiers.

  2000cited by this paper
• Multidrug resistance transporters and modulation

  2000cited by this paper
• Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo.

  2000cited by this paper
• An inventory of the human ABC proteins.

  1999cited by this paper
• Effects of a potent and specific P-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat.

  1999cited by this paper
• Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cells.

  1999cited by this paper
• Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR.

  1999cited by this paper
• Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier.

  1999cited by this paper
• Organic cation transport in rat choroid plexus cells studied by fluorescence microscopy.

  1999cited by this paper
• Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles

  1999cited by this paper
• The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter.

  1999cited by this paper
• P-Glycoprotein on astrocyte foot processes of unfixed isolated human brain capillaries.

  1999cited by this paper
• The mouse Bcrp1/Mxr/Abcp gene: amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin.

  1999cited by this paper
• Mrp1 Multidrug Resistance‐Associated Protein and P‐Glycoprotein Expression in Rat Brain Microvessel Endothelial Cells

  1998cited by this paper
• Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C.

  1998cited by this paper
• A general pattern for substrate recognition by P-glycoprotein.

  1998cited by this paper
• A multidrug resistance transporter from human MCF-7 breast cancer cells.

  1998cited by this paper
• Characterization of efflux transport of organic anions in a mouse brain capillary endothelial cell line.

  1998cited by this paper
• Function, evolution and structure of multidrug resistance protein (MRP).

  1997cited by this paper
• Identification of a P-glycoprotein-deficient subpopulation in the CF-1 mouse strain using a restriction fragment length polymorphism.

  1997cited by this paper
• Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein.

  1997cited by this paper
• Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833.

  1997cited by this paper
• Brain Microvascular and Astrocyte Localization of P‐Glycoprotein

  1997cited by this paper
• Structure of the multidrug resistance P-glycoprotein.

  1997cited by this paper
• Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins.

  1997cited by this paper
• Multidrug transporters from bacteria to man: similarities in structure and function.

  1997cited by this paper
• Cellular localization of P-glycoprotein in brain versus gonadal capillaries.

  1996cited by this paper
• P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.

  1996cited by this paper
• Functional Expression of P‐Glycoprotein in an Immortalised Cell Line of Rat Brain Endothelial Cells, RBE4

  1996cited by this paper

• From Polyphenols to Prodrugs: Bridging the Blood–Brain Barrier with Nanomedicine and Neurotherapeutics

  2026cites this paper
• Intranasally Delivered Mesenchymal Stem Cells Reverses Prodromal Non-Motor Deficits and Nigral Loss in a Parkinson’s Disease Mouse Model

  2026cites this paper
• Advances in carbon nanomaterials and their polymeric composites in neural tissue engineering.

  2025cites this paper
• Dihydropyrimidines Emerge as Promising Dual‐Acting Inhibitors Targeting Acetylcholinesterase and Monoamine Oxidases for Alzheimer's and Other Neurological Disorders

  2025cites this paper
• Targeted and Untargeted Proteomics-based Comparison of Adenoviral Infected hCMEC/D3 and hBMEC as a Human Brain Endothelial Cells to Study the OATP2B1 Transporter

  2025cites this paper
• Neisseria meningitidis regulates P-glycoprotein transporter activity in brain endothelial cells via sphingosine 1–phosphate receptor 1

  2025cites this paper
• Gatekeeper of the brain: unraveling the role of ABCB1 in Parkinson’s disease progression and therapy

  2025cites this paper
• Crossing the Blood–Brain Barrier with Molecularly Imprinted Polymeric Nanocarriers: An Emerging Frontier in Brain Disease Therapy

  2025cites this paper
• Imagerie moléculaire pour l’étude des répercussions pharmacocinétiques des transporteurs hépatiques

  2025cites this paper
• The microcirculation, the blood-brain barrier, and the neurovascular unit in health and Alzheimer disease: The aberrant pericyte is a central player

  2025cites this paper
• Crossing the Borders: the amino acid transporter LAT1 (SLC7A5) in the Blood-Brain Barrier.

  2025cites this paper
• Novel single-domain antibodies targeting a unique transferrin receptor 1 epitope for cross-species delivery of drugs in the central nervous system.

  2025cites this paper
• A new era in brain drug delivery: Integrating multivalency and computational optimisation for blood-brain barrier permeation.

  2025cites this paper
• Targeting HER2 in breast cancer with brain metastases: a pharmacological point of view with special focus on the permeability of blood-brain barrier to targeted treatments.

  2024cites this paper
• Delivery of Neuroregenerative Proteins to the Brain for Treatments of Neurodegenerative Brain Diseases

  2024cites this paper
• Mosaic deletion of claudin-5 reveals rapid non-cell-autonomous consequences of blood-brain barrier leakage.

  2024cites this paper
• A small‐molecule microtubule‐stabilizing agent safely reduces Aβ plaque and tau pathology in transgenic mouse models of Alzheimer's disease

  2024cites this paper
• Identification of NanoLuciferase Substrates Transported by Human ABCB1 and ABCG2 and Their Zebrafish Homologs at the Blood-Brain Barrier

  2024cites this paper
• PERMEABILITY OF THE BLOOD-BRAIN BARRIER IN TOXIC PARKINSONISM

  2024cites this paper
• Tailoring N, N, N‐trimethyl chitosan nanospheres as an efficient drug carrier to overcome endothelial barrier

  2024cites this paper
• Nose-to Brain Delivery of Resveratrol, a Non-Invasive Method for the Treatment of Cerebral Ischemia

  2024cites this paper
• Effect of Apolipoprotein E isoforms on the Abundance and Function of P-glycoprotein in Human Brain Microvascular Endothelial Cells

  2024cites this paper
• Receptor-Assisted Nanotherapeutics for Overcoming the Blood–Brain Barrier

  2024cites this paper
• Nose to Brain: Exploring the Progress of Intranasal Delivery of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers

  2024cites this paper
• Nanoparticle-Based Combinational Strategies for Overcoming the Blood-Brain Barrier and Blood-Tumor Barrier

  2024cites this paper
• A Computational Physics-based Approach to Predict Unbound Brain-to-Plasma Partition Coefficient, Kp,uu

  2023cites this paper
• Drug Permeability: From the Blood–Brain Barrier to the Peripheral Nerve Barriers

  2023cites this paper
• Regional contribution of vascular dysfunction in white matter dementia: clinical and neuropathological insights

  2023cites this paper
• Universal method for the gentle isolation of intact microvessels from frozen tissue: a multiomic investigation into the neurovasculature

  2023cites this paper
• Modification Strategies of Anti-Transferrin Receptor Antibody across the Blood-Brain Barrier

  2023cites this paper
• Utilizing machine learning techniques to predict the blood-brain barrier permeability of compounds detected using LCQTOF-MS in Malaysian Kelulut honey

  2023cites this paper
• Endovascular Chemotherapy: Selective Targeting for Brain Cancer

  2023cites this paper
• Hippocampal Vascular Supply and Its Role in Vascular Cognitive Impairment

  2023cites this paper
• Permeability of Metformin across an In Vitro Blood–Brain Barrier Model during Normoxia and Oxygen-Glucose Deprivation Conditions: Role of Organic Cation Transporters (Octs)

  2023cites this paper
• An Improved In Vitro Blood-Brain Barrier Model for the Evaluation of Drug Permeability Using Transwell with Shear Stress

  2023cites this paper
• Liposome-Mediated Anti-Viral Drug Delivery Across Blood–Brain Barrier: Can Lipid Droplet Target Be Game Changers?

  2023cites this paper
• Identification of NanoLuciferase Substrates Transported by Human ABCB1 and ABCG2 and their Zebrafish Homologs at the Blood-Brain Barrier

  2023cites this paper
• Strategies facilitating the permeation of nanoparticles through blood-brain barrier: An insight towards the development of brain-targeted drug delivery system

  2023cites this paper
• Universal method for the isolation of microvessels from frozen brain tissue: A proof-of-concept multiomic investigation of the neurovasculature

  2023cites this paper
• BCRP drives intrinsic chemoresistance in chemotherapy-naïve breast cancer brain metastasis

  2023cites this paper
• Molecular Heterogeneity of the Brain Endothelium

  2023cites this paper
• Development of Prodrugs for Treatment of Parkinson's Disease: New Inorganic Scaffolds for Blood-Brain Barrier Permeation.

  2022cites this paper
• European Journal of Pharmaceutics and Biopharmaceutics "Re-evaluation of the hCMEC/D3 based in vitro BBB model for ABC transporter studies".

  2022cites this paper
• A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics

  2022cites this paper
• Targeting Transporters for Drug Delivery to the Brain: Can We Do Better?

  2022cites this paper
• Polymer nanocarriers for targeted local delivery of agents in treating brain tumors

  2022cites this paper
• Transcriptomic analysis of a 3D blood–brain barrier model exposed to disturbed fluid flow

  2022cites this paper
• Regulation of P-glycoprotein and Breast Cancer Resistance Protein Expression Induced by Focused Ultrasound-Mediated Blood-Brain Barrier Disruption: A Pilot Study

  2022cites this paper
• Developing a transwell millifluidic device for studying blood-brain barrier endothelium.

  2022cites this paper
• Analysis of influencing factors on monohydroxylated derivative of oxcarbazepine plasma concentration in children with epilepsy

  2022cites this paper
• Current status and future directions for a neurotoxicity hazard assessment framework that integrates in silico approaches.

  2022cites this paper
• Vascular endothelial cells: a fundamental approach for brain waste clearance.

  2022cites this paper
• Synthesis of N, N, N-Trimethyl Chitosan-based Nanospheres for The Prolonged Release of Curcumin

  2022cites this paper
• Brain Drug Delivery and Neurodegenerative Diseases: Polymeric PLGA-Based Nanoparticles as a Forefront Platform.

  2022cites this paper
• Nanomedicine for Glioblastoma: Progress and Future Prospects.

  2022cites this paper
• Blood–brain barrier: emerging trends on transport models and new-age strategies for therapeutics intervention against neurological disorders

  2022cites this paper
• ABCC1 modulates negative feedback control of the hypothalamic-pituitary-adrenal axis in vivo in humans

  2022cites this paper
• Plastic structures for diverse substrates: A revisit of human ABC transporters

  2022cites this paper
• Perfluorooctanesulfonic acid exposure altered hypothalamic metabolism and disturbed male fecundity.

  2022cites this paper
• Structural basis of drug recognition by the multidrug transporter ABCG2

  2021cites this paper
• Interactions of SARS-CoV-2 with the Blood–Brain Barrier

  2021cites this paper
• In vitro biomimetic models for glioblastoma-a promising tool for drug response studies.

  2021cites this paper
• Disease-Induced Modulation of Drug Transporters at the Blood–Brain Barrier Level

  2021cites this paper
• Drug delivery and targeting to brain tumors: considerations for crossing the blood-brain barrier

  2021cites this paper
• Assessment of Brain-To-Blood Drug Distribution Using Liquid Chromatography.

  2021cites this paper
• Bile duct ligation causes opposite impacts on the expression and function of BCRP and P-gp in rat brain partly via affecting membrane expression of ezrin/radixin/moesin proteins

  2021cites this paper
• Role of Impaired ABC Transporters in Alzheimer’s Disease

  2021cites this paper
• Blood–brain barrier disruption in atrial fibrillation: a potential contributor to the increased risk of dementia and worsening of stroke outcomes?

  2021cites this paper
• Lipid nanostructures for targeting brain cancer

  2021cites this paper
• The roles of the human ATP-binding cassette transporters P-glycoprotein and ABCG2 in multidrug resistance in cancer and at endogenous sites: future opportunities for structure-based drug design of inhibitors

  2021cites this paper
• The Function and Expression of ATP-Binding Cassette Transporters Proteins in the Alzheimer's Disease

  2021cites this paper
• Evaluation of human peptide/histidine transporter 1 (hPHT1/SLC15A4) function: transport kinetics utilizing a HPHT1 shRNA stably transfected knockdown in the hCMEC/D3 blood-brain barrier cell line

  2021cites this paper
• Drug Penetration into the Central Nervous System: Pharmacokinetic Concepts and In Vitro Model Systems

  2021cites this paper
• Intranasal gene therapy for the treatment of neurological disorders

  2021cites this paper
• Xenobiotic Transport and Metabolism in the Human Brain.

  2021cites this paper
• Abnormal amyloid beta metabolism in systemic abnormalities and Alzheimer's pathology: Insights and therapeutic approaches from periphery.

  2021cites this paper
• Blood-brain barrier models: rationale for selection.

  2021cites this paper
• Role of microRNAs in glioblastoma

  2021cites this paper
• The Blood–Brain Barrier and CNS Drug Delivery

  2021cites this paper
• The complexity of the blood-brain barrier and the concept of age-related brain targeting: challenges and potential of novel solid lipid-based formulations.

  2021cites this paper
• Emerging Application of Nanorobotics and Artificial Intelligence To Cross the BBB: Advances in Design, Controlled Maneuvering, and Targeting of the Barriers.

  2021cites this paper
• Current State of Targeted Radiometal-Based Constructs for the Detection and Treatment of Disease in the Brain.

  2021cites this paper
• Pro- and Antiangiogenic Factors in Gliomas: Implications for Novel Therapeutic Possibilities

  2021cites this paper
• In vitro blood–brain barrier model derived from human iPS cells and its applications

  2021cites this paper
• Applications of Exosomes in Targeted Drug Delivery for the Treatment of Parkinson's Disease: A Review of Recent Advances and Clinical Challenges.

  2020cites this paper
• Induction of Transporter Protein Glycoprotein-P in the Blood–Brain Barrier as a Way to Prevent Parkinson’s Syndrome

  2020cites this paper
• Age-related ultrastructural neurovascular changes in the female mouse cortex and hippocampus.

  2020cites this paper
• Insulin resistance and bioenergetic manifestations: Targets and approaches in Alzheimer's disease.

  2020cites this paper
• Physiology of the cerebrovascular adaptation to pregnancy.

  2020cites this paper
• Preclinical models to optimize treatment of tuberculous meningitis - A systematic review.

  2020cites this paper
• Dysfunction of ABC transporters at the blood-brain barrier: Role in neurological disorders.

  2020cites this paper
• Intertwined mechanisms define transport of anti-ICAM nanocarriers across the endothelium and brain delivery of a therapeutic enzyme.

  2020cites this paper
• Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.

  2020cites this paper
• Kinetic interactions of nanocomplexes between astaxanthin esters with different molecular structures and β-lactoglobulin.

  2020cites this paper
• Influence of transporters in treating cancers in the CNS

  2020cites this paper
• The Blood-Brain Barrier Interface in Diabetes Mellitus: Dysfunctions, Mechanisms, and Approaches to Treatment.

  2020cites this paper
• Revisiting the Blood-brain barrier: A hard nut to crack in the transportation of drug Molecules.

  2020cites this paper
• A Spectrum of Topics for 2019: Advances in Neuroinflammation, Oxidative Stress, Obesity, Diabetes Mellitus, Cardiovascular Disease, Autism, Exosomes, and Central Nervous System Diseases.

  2020cites this paper
• Hydroxysafflor Yellow A Together with Blood–Brain Barrier Regulator Lexiscan for Cerebral Ischemia Reperfusion Injury Treatment

  2020cites this paper
• Novel therapeutics for brain tumors: current practice and future prospects

  2020influential citation